<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.5-a.1'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//medicinacardiometabolica.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/15/eeuu-319-psyllium-metamucil-para-que-sirve/</loc>
  <lastmod>2026-11-15T16:21:05Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Psyllium (Metamucil): para qué sirve, dosis, efectos secundarios y precio (2026)</news:title>
   <news:publication_date>2026-11-15T16:19:17Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/15/glp1-naion-aviso-fda-radar/</loc>
  <lastmod>2026-11-15T11:26:36Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>GLP-1 y NAION: aviso FDA &amp;#124; Radar cardiometabólico 15 nov</news:title>
   <news:publication_date>2026-11-15T11:22:43Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/15/obesidad-glp1-aha-2026-beneficio-cardiovascular-probado-seguridad-mace/</loc>
  <lastmod>2026-11-15T11:12:15Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Obesidad y GLP-1 en AHA 2026: qué fármacos tienen beneficio cardiovascular probado y cuáles solo seguridad en MACE</news:title>
   <news:publication_date>2026-11-15T11:12:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/14/podcast-semanal-diabetes-aldosterona-semiologia-2026-11-14/</loc>
  <lastmod>2026-11-15T01:59:44Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Podcast semanal: diabetes ADA/EASD 2026, aldosterona y obesidad, semiología y pruebas diagnósticas</news:title>
   <news:publication_date>2026-11-15T01:59:44Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/14/mcm-eje-cardiorrenal-dia-45/</loc>
  <lastmod>2026-11-14T22:13:17Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Eje cardiorrenal: cómo se dañan mutuamente corazón y riñón &amp;#124; Medicina Cardiometabólica · Día 45</news:title>
   <news:publication_date>2026-11-14T22:13:17Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/14/endo-indice-homa-ir-dia-45/</loc>
  <lastmod>2026-11-14T22:11:55Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Índice HOMA-IR: cálculo, interpretación y utilidad real &amp;#124; Endocrinología · Día 45</news:title>
   <news:publication_date>2026-11-14T22:11:55Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/14/cardio-clasificacion-soplos-ciclo-cardiaco-dia-45/</loc>
  <lastmod>2026-11-14T22:10:47Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Soplos cardiacos según su momento en el ciclo cardiaco &amp;#124; Cardiología · Día 45</news:title>
   <news:publication_date>2026-11-14T22:10:47Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/14/disnea-enfoque-semiologico/</loc>
  <lastmod>2026-11-14T22:12:10Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Disnea: diagnóstico diferencial con LR al pie de cama</news:title>
   <news:publication_date>2026-11-14T22:10:16Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/14/mi-examen-completo-orina-dia-45/</loc>
  <lastmod>2026-11-14T22:09:18Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Examen completo de orina: densidad, pH, proteinuria, hematuria y sedimento &amp;#124; Medicina Interna · Día 45</news:title>
   <news:publication_date>2026-11-14T22:09:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/14/eeuu-318-medicare-bomba-insulina-2027/</loc>
  <lastmod>2026-11-14T16:19:32Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Bombas de insulina y sistemas híbridos: cobertura y precio 2027</news:title>
   <news:publication_date>2026-11-14T16:19:32Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/14/diabetes-tipo-2-2026-ada-easd-guia-diagnostico-metas-tratamiento/</loc>
  <lastmod>2026-11-14T11:08:07Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Diabetes tipo 2 2026 ADA/EASD: guía completa de diagnóstico, metas y algoritmo de tratamiento por comorbilidad</news:title>
   <news:publication_date>2026-11-14T11:08:07Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/13/mcm-actividad-simpatica-obesidad-hipertension-dia-44/</loc>
  <lastmod>2026-11-13T22:20:12Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Actividad simpática en la obesidad y su papel en la hipertensión &amp;#124; Medicina Cardiometabólica · Día 44</news:title>
   <news:publication_date>2026-11-13T22:20:12Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/13/endo-prueba-combinada-estimulacion-hipofisaria-dia-44/</loc>
  <lastmod>2026-11-13T22:17:21Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Prueba combinada de estimulación hipofisaria en el panhipopituitarismo &amp;#124; Endocrinología · Día 44</news:title>
   <news:publication_date>2026-11-13T22:17:21Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/13/tromboembolismo-pulmonar-semiologia-score/</loc>
  <lastmod>2026-11-13T22:17:03Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Tromboembolismo pulmonar: semiología y score de Wells</news:title>
   <news:publication_date>2026-11-13T22:15:48Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/13/cardio-chasquido-apertura-estenosis-mitral-dia-44/</loc>
  <lastmod>2026-11-13T22:14:29Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Chasquido de apertura en la estenosis mitral reumática &amp;#124; Cardiología · Día 44</news:title>
   <news:publication_date>2026-11-13T22:14:29Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/13/mi-procalcitonina-infeccion-bacteriana-dia-44/</loc>
  <lastmod>2026-11-13T22:11:39Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Procalcitonina en la sospecha de infección bacteriana &amp;#124; Medicina Interna · Día 44</news:title>
   <news:publication_date>2026-11-13T22:11:39Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/13/eeuu-317-grasa-abdominal-medida-riesgo/</loc>
  <lastmod>2026-11-13T16:38:29Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Grasa abdominal: qué medida es riesgo y cómo medirla bien</news:title>
   <news:publication_date>2026-11-13T16:38:29Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/13/enarm-016-parto-normal/</loc>
  <lastmod>2026-11-13T11:21:46Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Parto Normal ENARM 2026: Caso Clínico Paso a Paso</news:title>
   <news:publication_date>2026-11-13T11:21:46Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/11/13/hipertension-aha-2026-espironolactona-reduce-optimal-diabetes-lorundrostat/</loc>
  <lastmod>2026-11-13T11:09:32Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Hipertensión en AHA 2026: espironolactona baja 7,7 mmHg tras ictus y la meta de 120 mmHg no reduce eventos en diabetes</news:title>
   <news:publication_date>2026-11-13T11:09:32Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>